TB 500 - Kalpa Pharmaceuticals

Buy TB 500 5 mg by Kalpa Pharmaceuticals at XSteroids. This thymosin beta-4 fragment arrives from Kalpa as one glass vial of lyophilised powder for laboratory use. Below is the chemistry, the actin-binding mechanism, the gap between animal findings and human reality, the mixing arithmetic and the anti-doping position, together with a plain account of what you are buying.

The status belongs first: TB 500 is a research product sold for laboratory work, and there is no licensed medicine form of it. No human study of this fragment exists, and whatever clinical evidence there is describes the parent protein rather than this fragment. None of it forms a dosing schedule or medical guidance.

What TB 500 5 mg Is and What You Are Buying

Chemically the peptide is Ac-LKKTETQ, an N-acetylated chain of seven residues that mirrors positions 17 to 23 of thymosin beta-4. Its registry markers are CAS 885340-08-9 and PubChem 62707662, with the molecular formula C38H68N10O14. The full protein runs to 43 residues and roughly 4921 g/mol, coded by the gene TMSB4X.

The pack is one sealed vial of white powder at the 5 mg strength, with bacteriostatic water listed separately. Kalpa prints the mass on the label; no filler list and no batch potency certificate appear here, so the contents rest on the manufacturer. Every number quoted below comes from the label or the published literature, never from guesswork about the glass.

How TB 500 Works Through the LKKTET Actin Motif

The active region is the short LKKTET sequence. It binds G-actin, the unpolymerised form of the protein, and by doing so shapes how actin filaments assemble, how cells move and how they migrate. Actin remodelling underlies wound closure and tissue rebuilding, which is why the literature ties the peptide to those processes instead of to a cell-surface receptor.

Extracellular effects of the parent protein appear to travel by routes that never touch actin, so the published picture is not tidy. Vendor pages add actin binding, new blood vessel growth, lower pro-inflammatory cytokines, more collagen and keratinocyte migration to the list; those are marketing statements rather than clinical findings and should be read that way.

What to Expect from TB 500 in Repair Research

The human evidence is absent. TB 500 has not been studied in people, and the one clinical setting where the parent protein was tried uses eye drops, a different route and a different molecule. Preclinical work reports quicker tissue repair and anti-inflammatory shifts, but that is animal and cell-culture data which cannot yield a human effect size.

One claim deserves a direct correction. Several sellers describe TB 500 as a seventeen amino acid fragment, while the chemical record describes a seven-residue acetylated peptide. Both versions circulate, and the honest position is that the scientific characterisation is the shorter one. Buyers comparing labels will meet this contradiction, so it is worth naming plainly.

Mixing the 5 mg TB 500 Vial for a U-100 Barrel

Fix the water volume first and the rest follows. Every millilitre added to the 5 mg fill cuts the strength per millilitre: one millilitre gives 5000 mcg in each millilitre, two millilitres halve it to 2500 mcg, and five millilitres bring it to 1000 mcg per millilitre. A U-100 barrel marks hundredths of a millilitre, so ten marks always stand for 0.1 ml, which then carries 500 mcg, 250 mcg or 100 mcg depending on the dilution chosen.

Let the water run down the inner wall instead of onto the powder, swirl rather than shake, and label the vial with its strength per millilitre and the day it was mixed. Those two details keep later draws consistent. A 5 mg fill is small, which suits one mixing session better than repeated ones.

Stacking the TB 500 Vial With Other Repair Peptides

TB 500 is almost always discussed beside a second repair agent, and the frequent partner is the BPC 157 pentadecapeptide. BPC 157 2 mg is examined for local tissue and gut effects, while TB 500 is read as systemic and actin-binding, so the two approach repair from different sides on paper. Neither is a medicine.

The third member of this shelf is the copper peptide GHK-CU 50 mg, studied mainly for skin and connective tissue. All three arrive dry and draw from one shared water line, bacteriostatic water.

The growth-hormone row is a different shelf rather than a partner for this vial. It holds the ghrelin-receptor secretagogue Ipamorelin 5 mg and the GHRH peptide Sermorelin 5 mg, both of which work by prompting the pituitary rather than by touching actin. Sharing a bench and a diluent does not make them interchangeable with TB 500, so a study that puts the two groups side by side is running two separate experiments.

Recovery Notes for a Repair Peptide Study

A repair peptide works on tissue pathways rather than the androgen axis, so it causes none of the shutdown that a post-cycle plan exists to undo. Nothing needs restarting when a study ends. What matters is local instead: the state of the injection site, swelling that will not settle, and whether an injury is being allowed to heal.

Where such a vial is studied beside an anabolic course, the recovery plan stays with the anabolic compound. Kalpa keeps that shelf apart, and a peptide block leaves it untouched. The prescription route on that line is Kalpatropin, which supplies growth hormone rather than prompting the body to make it. Because TB 500 has no licensed medicine form, there is no label instruction on duration or stopping rules, and the honest position is that the researcher defines the block rather than a guideline.

TB 500 Side Effects and Anti-Doping Status

No human safety profile exists, because the human dataset is empty. Animal work flags no organ toxicity at the amounts used, but the absence of an animal signal is not a safety finding in people. As a laboratory-grade item it stands outside pharmaceutical manufacturing controls, so purity and exact mass come down to the supplier.

In sport the verdict is unambiguous. WADA lists thymosin beta-4 and its derivatives, with TB 500 named as the example, inside class S2, and the prohibition is permanent. There is no in-competition window and no therapeutic-use route for this substance.

Handling and Storing the TB 500 Vial

Keep the sealed lyophilisate between 2 and 8 C in the refrigerator and out of the light. Dry powder also tolerates short spells at a controlled 15 to 25 C, but it must not be frozen, since ice crystals harm the peptide backbone. Cool and dark, the dry vial keeps for a long time.

After mixing, hold the solution at 2 to 8 C and finish it inside a 28 to 30 day window, the life peptide practice allows a reconstituted vial. Throw away any solution that has been frozen and thawed, or that has clouded or carries floating specks. Keep it away from children.

Why Buy TB 500 from XSteroids?

This 5 mg vial sits in the Kalpa Pharmaceuticals catalog at XSteroids beside the partner peptides and the diluent they need, so a bench can be equipped in one order. The checkout is encrypted; domestic US parcels usually arrive inside 3 to 6 days and international orders in 12 to 26 days. The vials usually mixed in the same session as this one are linked below.